
    
      Glucose is a potent stimulus for GLP-1 secretion after gastric bypass surgery and the SGLT-1
      transporter appears to be crucial for this response. The study will investigate the effects
      of SGLT-1/SGLT-2 inhibition (by canagliflozin) on secretion of GLP-1 and other gut hormones
      after gastric bypass surgery.
    
  